Gabriella Pagnan

Medicine · Health Sciences

29h-index2.5kcitations80works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuroblastoma Research and Treatments(55), Cell death mechanisms and regulation(24), Retinoids in leukemia and cellular processes(16), Lung Cancer Research Studies(15), Ubiquitin and proteasome pathways(10)

Publications80 total

Supplementary Data from Enhanced Antitumor Efficacy of Clinical-Grade Vasculature-Targeted Liposomal Doxorubicin
2023Open Access
Data from The Combined Therapeutic Effects of Bortezomib and Fenretinide on Neuroblastoma Cells Involve Endoplasmic Reticulum Stress Response
2023Open Access
Data from The Combined Therapeutic Effects of Bortezomib and Fenretinide on Neuroblastoma Cells Involve Endoplasmic Reticulum Stress Response
2023Open Access
Data from Enhanced Antitumor Efficacy of Clinical-Grade Vasculature-Targeted Liposomal Doxorubicin
2023Open Access
Supplementary Data from The Combined Therapeutic Effects of Bortezomib and Fenretinide on Neuroblastoma Cells Involve Endoplasmic Reticulum Stress Response
2023Open Access
Supplementary Data from Enhanced Antitumor Efficacy of Clinical-Grade Vasculature-Targeted Liposomal Doxorubicin
2023Open Access
Data from Enhanced Antitumor Efficacy of Clinical-Grade Vasculature-Targeted Liposomal Doxorubicin
2023Open Access
Supplementary Data from The Combined Therapeutic Effects of Bortezomib and Fenretinide on Neuroblastoma Cells Involve Endoplasmic Reticulum Stress Response
2023Open Access
Supplementary Figure 1 from Therapeutic Targeting of TLR9 Inhibits Cell Growth and Induces Apoptosis in Neuroblastoma
2023Open Access
Supplementary Methods and Figure Legend from Targeting Liposomal Chemotherapy via Both Tumor Cell–Specific and Tumor Vasculature–Specific Ligands Potentiates Therapeutic Efficacy
2023Open Access
Supplementary Figure S1 from Targeting Liposomal Chemotherapy via Both Tumor Cell–Specific and Tumor Vasculature–Specific Ligands Potentiates Therapeutic Efficacy
2023Open Access
Supplementary Methods from Therapeutic Targeting of TLR9 Inhibits Cell Growth and Induces Apoptosis in Neuroblastoma
2023Open Access
Supplementary Methods from Therapeutic Targeting of TLR9 Inhibits Cell Growth and Induces Apoptosis in Neuroblastoma
2023Open Access
Supplementary Methods and Figure Legend from Targeting Liposomal Chemotherapy via Both Tumor Cell–Specific and Tumor Vasculature–Specific Ligands Potentiates Therapeutic Efficacy
2023Open Access
Data from Therapeutic Targeting of TLR9 Inhibits Cell Growth and Induces Apoptosis in Neuroblastoma
2023Open Access
Data from Targeting Liposomal Chemotherapy via Both Tumor Cell–Specific and Tumor Vasculature–Specific Ligands Potentiates Therapeutic Efficacy
2023Open Access
Data from Targeting Liposomal Chemotherapy via Both Tumor Cell–Specific and Tumor Vasculature–Specific Ligands Potentiates Therapeutic Efficacy
2023Open Access
Supplementary Figure S1 from Targeting Liposomal Chemotherapy via Both Tumor Cell–Specific and Tumor Vasculature–Specific Ligands Potentiates Therapeutic Efficacy
2023Open Access
Supplementary Figure 1 from Therapeutic Targeting of TLR9 Inhibits Cell Growth and Induces Apoptosis in Neuroblastoma
2023Open Access
Data from Therapeutic Targeting of TLR9 Inhibits Cell Growth and Induces Apoptosis in Neuroblastoma
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Mirco Ponzoni(44), Fabio Pastorino(33), Chiara Brignole(29), Danilo Marimpietri(23), Daniela Di Paolo(21), Theresa M. Allen(17), Monica Loi(16), Michele Cilli(15), Doménico Ribatti(11), Vito Pistoia(11), Patrizia Perri(11), Lizzia Raffaghello(9), Irene Caffa(8), Federica Piccardi(7), Paolo G. Montaldo(7), Ida Casciano(6), Barbara Banelli(6), Giorgio Allemanni(6), Massimo Romani(6), Carla Rozzo(6)